Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Johnson & Johnson HIV combination succeeds in mid-stage study
Yahoo/Reuters
Tue, 11/3/15 - 09:20 am
Tags:
JNJ, HIV, cabotegravir, rilpivirine, ViiV Healthcare
4 Blockbuster Drugs Whose Sales Could Easily Double
Motley Fool
Mon, 10/26/15 - 08:46 am
Tags:
Xtandi, Medivation, Astellas, Eliquis, Pfizer, Bristol-Myers Squibb, Revlimid, Celgene, Invokana, JNJ
FDA approves J&J's chemotherapy Yondelis
Yahoo/Reuters
Fri, 10/23/15 - 11:11 am
Tags:
FDA, JNJ, chemotherapy, Yondelis, soft tissue sarcomas
3 Healthcare Trends Johnson & Johnson Told Us About This Earnings Season
Motley Fool
Thu, 10/22/15 - 09:59 am
Tags:
JNJ, earnings, emerging markets, anticoagulants
Johnson & Johnson Tells Gilead Sciences "Game On"
Motley Fool
Tue, 10/20/15 - 10:08 am
Tags:
JNJ, Gilead Sciences, hepatitis C, Olysio, Incivek, Harvoni, Sovaldi
J&J's Stelara succeeds in Phase III Crohn's disease trial
Yahoo/Reuters
Mon, 10/19/15 - 09:56 am
Tags:
JNJ, Stelara, Crohn's Disease, clinical trials
J&J's Earnings May Be Good News for Bristol-Myers Squibb and Medivation
Motley Fool
Mon, 10/19/15 - 09:39 am
Tags:
JNJ, earnings, Bristol-Myers Squibb, Medivation
J&J Defeats First Lawsuit on Tylenol's Link to Liver Damage
Bloomberg
Fri, 10/16/15 - 12:54 pm
Tags:
JNJ, Tylenol, liver damage
J&J Needs To Put Its Earnings To Better Use
Seeking Alpha
Thu, 10/15/15 - 03:53 pm
Tags:
JNJ, earnings
AbbVie's Humira, J&J's Invokana lead September's $231M in pharma TV ad spending
Fierce Pharma Marketing
Wed, 10/14/15 - 11:16 am
Tags:
AbbVie, Humira, JNJ, Invokana, drug ads
J&J says its diabetes drug should have same survival edge as Lilly's
Yahoo/Reuters
Tue, 10/13/15 - 06:15 pm
Tags:
JNJ, diabetes, Invokana, Jardiance
J&J's Still Mulling Acquisitions Amid $10 Billion Share Buyback
Bloomberg
Tue, 10/13/15 - 06:11 pm
Tags:
JNJ, share repurchase, M&A
J&J says Jardiance survival benefit likely to be seen by Invokana
Yahoo/Reuters
Tue, 10/13/15 - 12:13 pm
Tags:
JNJ, Jardiance, diabetes, Invokana
J&J Beats Profit Forecasts Even as Drug Sales Lag Estimates
Bloomberg
Tue, 10/13/15 - 09:46 am
Tags:
JNJ, earnings
What to Expect When Johnson & Johnson (JNJ) Reports Earnings Tomorrow
TheStreet.com
Mon, 10/12/15 - 09:54 am
Tags:
JNJ, earnings
3 ADHD Treatment Makers to Watch
Motley Fool
Mon, 10/12/15 - 08:49 am
Tags:
ADHD, Shire, JNJ, Eli Lilly
4 Things Johnson & Johnson Should Address When it Reports Its Q3 Results
Motley Fool
Sat, 10/10/15 - 09:09 am
Tags:
JNJ, earnings, Invokana, daratumumab, devices
Wyeth, Cordis bury the hatchet in stent patent spat with Abbott, Boston Scientific
Mass Device
Fri, 10/9/15 - 11:52 am
Tags:
Wyeth, Pfizer, Cordis, Abbott Labs, JNJ, Boston Scientific, devices, drug-eluting stents, patents, Xience
Boehringer's psoriasis drug beats Stelara in head-to-head Phase II
Fierce Biotech
Fri, 10/9/15 - 10:36 am
Tags:
Boehringer Ingelheim, JNJ, Stelara, psoriasis, BI 655066
J&J starts vaccine trial in Sierra Leone, even as Ebola fades
Yahoo/Reuters
Fri, 10/9/15 - 10:33 am
Tags:
JNJ, clinical trials, Sierra Leone, vaccines, ebola virus

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.